Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02141113 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).
A Phase 4 study of Adult Attention Deficit Hyperactivity Disorder, sponsored by Rochester Center for Behavioral Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT02141113 is a Phase 4 study of Adult Attention Deficit Hyperactivity Disorder that has completed, run by Rochester Center for Behavioral Medicine. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02141113, a Phase 4 study of Adult Attention Deficit Hyperactivity Disorder, has completed, sponsored by Rochester Center for Behavioral Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This is considered an investigator-initiated clinical research trial, which means that your study doctor is researching a particular medication (in this case a medication that is currently FDA- approved) for the treatment of AD/HD in individuals ages 6-17. The medication is guanfacine hydrochloride. The hypothesis is that this medication could be used in adults with Attention Deficit/Hyperactivity Disorder who have not received satisfactory results with their current stimulant ADHD medication. The study drug is investigational for use in adults. Investigational means it has not been approved by the U.S. Food and Drug Administration (FDA) for use in adults.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Guanfacine Hydrochloride
Study Locations (1)
Michigan
- Rochester Center for Behavioral Medicine - Rochester Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02141113
The ClinicalTrials.gov registry entry for NCT02141113 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rochester Center for Behavioral Medicine, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adult Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02141113 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02141113 about?
NCT02141113 is a clinical study titled "Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).". This is considered an investigator-initiated clinical research trial, which means that your study doctor is researching a particular medication (in this case a medication that is currently FDA- approved) for the treatment of AD/HD in individuals ages 6-17. The medication is guanfacine hydrochloride....
What is the current status of trial NCT02141113?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2012-11. Estimated completion is 2014-11.
What conditions does trial NCT02141113 study?
This clinical trial studies the following conditions: Adult Attention Deficit Hyperactivity Disorder.
What interventions are being tested in trial NCT02141113?
The interventions under investigation include: Placebo (OTHER), Guanfacine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT02141113?
This trial is sponsored by Rochester Center for Behavioral Medicine, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02141113 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adult Attention Deficit Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.